Capitolis Liquid Global Markets’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Sell
22,490
-149,561
-87% -$12.1M 0.01% 294
2026
Q1
$14.9M Buy
172,051
+122,051
+244% +$11.7M 0.09% 150
2025
Q4
$4.8M Sell
50,000
-260,000
-84% -$25.3M 0.03% 233
2025
Q3
$29.5M Sell
310,000
-764,200
-71% -$70.3M 0.24% 70
2025
Q2
$93.6M Buy
+1,074,200
New +$91.1M 0.69% 32

Other funds holding MDT

Capitolis Liquid Global Markets's MDT Position: Q2 2026 in Review

Capitolis Liquid Global Markets reduced its Medtronic (MDT) stake by 87% in Q2 2026, selling an estimated $12.1M and leaving 22,490 shares worth $1.76M. The position accounts for 0.01% of the portfolio, ranked #294.

Capitolis Liquid Global Markets first reported a position in MDT in Q2 2025 and has held it in 5 quarters since. The position peaked at $93.6M in Q2 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Capitolis Liquid Global Markets held 22,490 shares of Medtronic worth $1.76M as of Q2 2026.
  • Capitolis Liquid Global Markets sold 149,561 Medtronic shares in Q2 2026, an estimated $12.1M.
  • Medtronic made up 0.01% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #294 holding.
  • Capitolis Liquid Global Markets first reported a position in Medtronic in Q2 2025 and has held it in 5 quarters since.
  • Capitolis Liquid Global Markets's Medtronic position peaked at $93.6M in Q2 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.